Missing/wrong data?
Log in to edit
Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia
scientific article published on 12 September 2002
Author/s
author: Hagop Kantarjian, Stefan Faderl, Jorge Eduardo Cortes, Susan O'Brien, Mary Beth Rios, Francis Giles, Guillermo Garcia-Manero, Jianqin Shan, Moshe Talpaz
Work details
Publication date
September 12, 2002
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.